跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABE Australia Biotechnology Express NMN 23000 - TGA Drug Approval Details
Approvals
/
TGA
/
ABE Australia Biotechnology Express NMN 23000
Approved
STANDARD
ABE Australia Biotechnology Express NMN 23000
Australia Biotechnology Research Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
802bb5fb3d6f7457
Company
Australia Biotechnology Research Pty Ltd
Type
Standard
Approval Details
Approval Id
802bb5fb3d6f7457
Product Name
ABE Australia Biotechnology Express NMN 23000
Artg Id
339510
Artg Name
ABE Australia Biotechnology Express NMN 23000
Sponsor
Australia Biotechnology Research Pty Ltd
Company Detail Path
/organization/australia-biotechnology-research-pty-ltd
Artg Date
2020-07-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
802bb5fb3d6f7457
Type
Standard
Back to TGA Approvals
